A federal judge in New York has dismissed murder and weapons charges against Luigi Mangione, the man accused of killing UnitedHealthcare CEO Brian Thompson, effectively removing the possibility of the death penalty. This ruling represents a significant setback for federal prosecutors in the high-profile case.
Court Decision and Legal Reasoning
US District Judge Margaret Garnett in Manhattan determined that Supreme Court precedents required the dismissal of the murder charge, as it conflicted with the two stalking charges that Mangione continues to face. The judge noted that while the outcome might seem perplexing to the public, she was bound by legal constraints. Mangione, aged 27, now risks life imprisonment without parole if convicted on the remaining stalking counts.
During a court hearing, federal prosecutor Dominic Gentile informed Judge Garnett that authorities have yet to decide on an appeal. In her 39-page ruling, Garnett explained that the murder and weapons charges could only proceed if the stalking allegations constituted “crimes of violence.” She concluded they did not, since the force involved could stem from reckless rather than intentional actions, falling short of Supreme Court standards.
Garnett highlighted the apparent contradictions in the legal framework, stating that Mangione’s alleged actions—traveling across state lines to target a healthcare executive with a silenced handgun—clearly amounted to violent crime. However, she emphasized that her decision strictly followed judicial precedents, even if it appeared unusual to laypeople and legal professionals alike.
Background of the Case
Brian Thompson, who oversaw UnitedHealth Group’s health insurance operations, was fatally shot on December 4, 2024, outside a Hilton hotel in midtown Manhattan. Mangione entered a not guilty plea to all related charges and has remained in custody since his arrest in Pennsylvania five days after the incident.
Although officials universally denounced the killing, Mangione has garnered sympathy from segments of the public frustrated with escalating healthcare costs and insurance practices, positioning him as an unlikely figure of resistance in some circles.
Trial Timeline and Additional Proceedings
Jury selection for the federal case is set to commence in September, with the trial’s evidence phase starting on October 12. Separately, Mangione faces state charges in New York for murder, weapons possession, and forgery, to which he has also pleaded not guilty. No trial date has been established for the state proceedings.
Prosecutors in the state case encountered their own challenge in September when the judge dismissed two terrorism-related counts. In another ruling, Garnett denied Mangione’s request to suppress evidence from his backpack at the time of arrest, including a 9-millimeter pistol, silencer, and journal entries. She ruled that the search by local police was justified as standard procedure for potential hazards and supported by probable cause, with the items inevitably discoverable via a federal warrant.
